\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ physical\\ exam\\ findings\ \(0\)\
\-\ laboratory\\ workup\\ was\\ unrevealing\ \(0\)\
\-\ surgical\\ resection\ \(126\)\
\-\ axial\\ ct\\ images\\ demonstrate\\ an\\ enhancing\\ mass\\ arising\\ from\\ the\\ tail\\ of\\ the\\ pancreas\\.\\ octreotide\\ scan\\ images\\ reveal\\ radiotracer\\ accumulation\\ within\\ this\\ mass\\.\ \(0\)\
\-\ pancreatic\\ endocrine\\ neoplasm\ \(0\)\
\-\ endocrine\\ neoplasm\ \(2\)\
\-\ pancreatic\\ adenocarcinoma\ \(3\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ the\\ octreotide\\ scan\\ confirms\\ the\\ diagnosis\\ of\\ endocrine\\ neoplasm\\.\ \(0\)\
\-\ 66\\ year\\ old\\ asymptomatic\\ male\\ presents\\ with\\ elevated\\ transaminases\\.\ \(1\)\
\-\ in\\ this\\ particular\\ case\\,\\ there\\ was\\ no\\ predominant\\ hormone\\ production\\ from\\ the\\ mass\\.\\ it\\ contained\\ mixed\\ apud\\ cells\\ however\\ staining\\ for\\ gastrin\\,\\ insulin\\,\\ and\\ glucagon\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endocrine\\:\\ 0\\.39694585270816557\ \(0\)\
\-\ octreotide\\:\\ 0\\.32043054728000303\ \(0\)\
\-\ neoplasm\\:\\ 0\\.2491224486939415\ \(0\)\
\-\ pancreatic\\:\\ 0\\.2205532741637023\ \(0\)\
\-\ apud\\:\\ 0\\.194536281283322\ \(0\)\
\-\ glucagon\\:\\ 0\\.1858898023064265\ \(0\)\
\-\ gastrin\\:\\ 0\\.1749965270814374\ \(0\)\
\-\ unrevealing\\:\\ 0\\.16497377440045025\ \(0\)\
\-\ transaminases\\:\\ 0\\.16246206988809506\ \(0\)\
\-\ insulin\\:\\ 0\\.15462039740615882\ \(0\)\
\-\ scan\\:\\ 0\\.14434084347849485\ \(0\)\
\-\ staining\\:\\ 0\\.1415460419821188\ \(0\)\
\-\ mass\\:\\ 0\\.1393950296394728\ \(0\)\
\-\ predominant\\:\\ 0\\.13678754122167008\ \(0\)\
\-\ contained\\:\\ 0\\.13678754122167008\ \(0\)\
\-\ production\\:\\ 0\\.13065276675712972\ \(0\)\
\-\ hormone\\:\\ 0\\.12386179156304271\ \(0\)\
\-\ the\\:\\ 0\\.12136257952389953\ \(0\)\
\-\ tail\\:\\ 0\\.11997381334659589\ \(0\)\
\-\ particular\\:\\ 0\\.11871904903700556\ \(0\)\
\-\ accumulation\\:\\ 0\\.11753403079461931\ \(0\)\
\-\ confirms\\:\\ 0\\.11753403079461931\ \(0\)\
\-\ workup\\:\\ 0\\.1145787028924645\ \(0\)\
\-\ pancreas\\:\\ 0\\.11432928670373933\ \(0\)\
\-\ 66\\:\\ 0\\.1140827540037669\ \(0\)\
\-\ images\\:\\ 0\\.1125375008287887\ \(0\)\
\-\ radiotracer\\:\\ 0\\.10618459184366322\ \(0\)\
\-\ reveal\\:\\ 0\\.10232483976110322\ \(0\)\
\-\ mixed\\:\\ 0\\.10069412140485297\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.09942441064920614\ \(0\)\
\-\ arising\\:\\ 0\\.09665405503761565\ \(0\)\
\-\ from\\:\\ 0\\.09662419746036736\ \(0\)\
\-\ cells\\:\\ 0\\.09372548752391385\ \(0\)\
\-\ laboratory\\:\\ 0\\.08833481789467106\ \(0\)\
\-\ was\\:\\ 0\\.08478873139017169\ \(0\)\
\-\ this\\:\\ 0\\.08359858640130302\ \(0\)\
\-\ elevated\\:\\ 0\\.08292677937646495\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.08281334910349925\ \(0\)\
\-\ no\\:\\ 0\\.07911491358932768\ \(0\)\
\-\ resection\\:\\ 0\\.07797580462678054\ \(0\)\
\-\ enhancing\\:\\ 0\\.07620311586470634\ \(0\)\
\-\ however\\:\\ 0\\.07199941167253085\ \(0\)\
\-\ axial\\:\\ 0\\.07026632571000653\ \(0\)\
\-\ metastatic\\:\\ 0\\.06671600665761142\ \(0\)\
\-\ physical\\:\\ 0\\.0659585229915884\ \(0\)\
\-\ demonstrate\\:\\ 0\\.06323968314089569\ \(0\)\
\-\ diagnosis\\:\\ 0\\.06305972560848136\ \(0\)\
\-\ it\\:\\ 0\\.06226819734622883\ \(0\)\
\-\ exam\\:\\ 0\\.061235978854681246\ \(0\)\
\-\ case\\:\\ 0\\.06111295058437497\ \(0\)\
\-\ findings\\:\\ 0\\.06003651514597767\ \(0\)\
\-\ surgical\\:\\ 0\\.05912326911051216\ \(0\)\
\-\ presents\\:\\ 0\\.0585173568438088\ \(0\)\
\-\ within\\:\\ 0\\.056025775802832856\ \(0\)\
\-\ male\\:\\ 0\\.05416087870349158\ \(0\)\
\-\ disease\\:\\ 0\\.05106210361207129\ \(0\)\
\-\ there\\:\\ 0\\.04840202966383782\ \(0\)\
\-\ of\\:\\ 0\\.0476106400942113\ \(0\)\
\-\ an\\:\\ 0\\.046516506743869916\ \(0\)\
\-\ ct\\:\\ 0\\.04631126126112778\ \(0\)\
\-\ year\\:\\ 0\\.037488486886835454\ \(0\)\
\-\ for\\:\\ 0\\.03686956055446413\ \(0\)\
\-\ old\\:\\ 0\\.03600192437314166\ \(0\)\
\-\ in\\:\\ 0\\.03026124164417626\ \(0\)\
\-\ and\\:\\ 0\\.02513637812557093\ \(0\)\
\-\ with\\:\\ 0\\.023819543720161304\ \(0\)\
